Skip to content
  • Monday, 20 April 2026
  • 5:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk’s triple agonist UBT251 delivered up to 19.7% average weight loss in Phase 2 trial
Laboratory Automation & Robotics

Novo Nordisk’s triple agonist UBT251 delivered up to 19.7% average weight loss in Phase 2 trial

Lana Keisha Apr 20, 2026 0

Novo Nordisk, a global leader in diabetes and obesity care, has announced promising results from a Phase 2 trial of…

Read More
Houston Methodist Researchers Identify TDP43 Protein as a Primary Regulator of DNA Mismatch Repair Linking Neurodegeneration and CancerDaiichi Sankyo and Tempus AI collaborate on ADC clinical developmentOrsoBio’s LXR Inverse Agonist Shows Promise for Hard-to-Treat Triglyceride Disorders, Paving New Path Beyond GLP-1 DominanceNew Lipid-CLEM Imaging Technique Revolutionizes Visualization of Nanoscale Lipid Organization in Cellular Membranes
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine ModificationLLMOps in 2026: The 10 Tools Every Team Must Have
Novo Nordisk’s triple agonist UBT251 delivered up to 19.7% average weight loss in Phase 2 trialTWiV 1292: Clinical update with Dr. Daniel GriffinMolecular Switch Discovery in Sperm Metabolism Offers New Pathways for Infertility Treatment and Non-Hormonal ContraceptionCan live cell dynamics fix drug discovery’s efficacy problem?
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Novo Nordisk’s triple agonist UBT251 delivered up to 19.7% average weight loss in Phase 2 trial
Lana Keisha Apr 20, 2026
Microbiology & Immunology
TWiV 1292: Clinical update with Dr. Daniel Griffin
Lina Irawan Apr 20, 2026
Stem Cell & Regenerative Medicine
Molecular Switch Discovery in Sperm Metabolism Offers New Pathways for Infertility Treatment and Non-Hormonal Contraception
Dwi Wanna Apr 19, 2026
Laboratory Automation & Robotics
Can live cell dynamics fix drug discovery’s efficacy problem?
Lana Keisha Apr 19, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ